Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
FIDELIO-DKD was a phase 3 trial of finerenone, in addition to standard of care, in participants with T2DM, moderately advanced CKD (mean baseline eGFR was 44 mL/min/1.73 m 2 with a median UACR of 852 mg/g) with the majority (87%) having macroalbuminuria [100]
Signs that you are ready to increase After four weeks at your starting dose, evaluate these indicators
Proven Success: We have helped countless patients achieve their goals and improve their quality of life
The time it takes for tirzepatide to work varies based on individual metabolism, starting weight, and dose progression
US$ 27.15
US$ 28.21
US$ 24.53
